Want to track VERA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vera Therapeutics Inc. (VERA) Statistics
Valuation metrics
Market Cap 2.14B
Enterprise value 2.04B
Trailing P/E (ttm) -4.76
Forward P/E -
PEG ratio 0.12
Price/Sales (ttm) -
Price/Book (mrq) 4.91
Enterprise Value/Revenue -
Enterprise Value/EBITDA -5.17
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.85M
Average volume (90 days) 2.16M
Price summary
52-Week low 23.05
52-Week high 56.05
Beta -
50-Day moving average 32.27
200-Day moving average 35.51
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.75%
Return on equity -0.84%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -5.59
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.95
Total debt (mrq) -
Total Debt/Equity (mrq) 0.18
Current ratio (mrq) 10.92%
Book value per share (mrq) 5.68
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
